IFR US ECM Calendar
Pricings
Ithax Acquisition III (US, SPAC) ─ $200m IPO. 20m units (Primary) at $10.00. Each unit comprises one share and one-half warrant. CANT. Nasdaq “ITHAU”. Ithaca Capital Partners. Hospitality/leisure/AI/digital assets. 24 months. 100% in trust. Institutional investors indicated for 2.5m of sponsor warrants.
Twelve Seas Investment III (Cayman Islands, SPAC) ─ $150m IPO. 15m units (Primary) at $10.00. Each unit comprises one share and one-tenth right. COHEN. Nasdaq “TWLVU”. Dmitri Elkin. Energy (ex US). 24 months. 100% in trust.
Calendar
December 11: Adecoagro (Luxembourg, agriculture) ─ $300m FO. Fixed size (Primary) versus $8.32 at launch. JPM, BOFA, BTG, CITI, ITAU. Tether Investments indicating for up to $200m of shares sold in the offering.
December 11: Contineum Therapeutics (US, biotech) ─ $75m ABB. Fixed size (Primary) marketed at $12.25 fixed price $13.07 last sale. GS, LEER, STFL, RBC, WBLR.
December 11: Legence (US, engineering and construction) ─ $339.4m FO. 7m shares (Secondary) versus $48.48 at launch. GS, JEFF. Blackstone is the selling shareholder.
December 11: Miami International (US, financial services) ─ $309.2m FO. 6.8m shares (Secondary) versus $45.80 at launch. JPM, MS, PS.
December 11: T1 Energy (US, renewable energy) ─ $140m FO. Fixed size (Primary) versus $6.15 at launch. SANT, JPM. Concurrent $120m 5y cvt. Wall cross.
December 11: T1 Energy (US, renewable energy) ─ $120m 5y cvt marketed at 5.25%-5.75%, up 35%-40%. SANT, JPM. Concurrent $140m common offering. Wall cross.
December 11: Tenaya Therapeutics (US, biotech) ─ $50m ABB. Fixed size (Primary) marketed at $1.20 fixed price versus $1.36 last sale. LEER, PS. Wall cross.
December 11: Wealthfront (US, fintech) ─ $484.6m IPO. 34.6m shares (Primary, Secondary) at $12-$14. GS, JPM. Nasdaq "WLTH". BlackRock and Wellington Management have indicated for $150m combined of the offering.
December 16: Andersen Group (US, business services) ─ $176m IPO. 11m shares (Primary) at $14.00-$16.00. MS, UBS, DB, TRST, WF. NYSE “ANDG”. 7% DSP.
December 16: Medline (US, medical supplies) – $5.37bn IPO. 179m shares (Primary) at $26-$30. GS, MS, BOFA, JPM, BARC, CITI, DB, JEFF, UBS. Nasdaq "MDLN". Backed with $2.35bn of demand from cornerstone investors Bailie Gifford, Capital Research Global Investors, Morgan Stanley, Durable Capital, GIC, Janus Henderson, Viking Global and WCM Investment Management. Members of the founding Mills Family indicating interest in purchasing up to $250m of offered shares.